Status:
UNKNOWN
Application of Genetic Polymorphisms of DNA Repair in The Prediction of Prostate Cancer Susceptibility and Its Clinical Outcome
Lead Sponsor:
National Taiwan University Hospital
Conditions:
Prostate Cancer
Eligibility:
MALE
Brief Summary
Primary: to investigate the effects of DNA repair gene polymorphisms on prostate cancer susceptibility, pathological grade, disease stage and clinical outcome Secondary: to understand the association ...
Detailed Description
DNA repair plays a key role in carcinogenesis through the removal and repair of DNA damage induced by endogenous and environmental sources. The DNA repair system included four pathways: 1) Base Excisi...
Eligibility Criteria
Inclusion
- prostate cancer approved by pathology
Exclusion
- combined with other malignancy
- accepting blood transfusion within 6 months
Key Trial Info
Start Date :
March 1 2005
Trial Type :
OBSERVATIONAL
End Date :
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT00167024
Start Date
March 1 2005
Last Update
November 28 2005
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Taiwan University Hospital
Taipei, Taiwan